Adhera Therapeutics, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Adhera Therapeutics, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2020-12-31, per its 10-K filed 2021-04-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2021-04-07
- 2020-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2020-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2020-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2020-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-04-07 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-18 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-19 |
| 2020-03-31 | $0.00 10-Q · filed 2020-07-06 |
| 2019-12-31 | $0.00 10-K · filed 2021-04-07 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-19 |
| 2018-12-31 | $0.00 10-K · filed 2020-04-14 |
| 2017-09-30 | $363.34K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $255.51K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $244.79K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $141.72K 10-K · filed 2018-04-17 |
| 2016-09-30 | $109.00K 10-Q · filed 2016-11-21 |
| 2015-12-31 | $2.55M 10-Q · filed 2016-11-21 |
| 2014-09-30 | $15.52M 10-Q · filed 2014-11-14 |
| 2013-12-31 | $6.25M 10-Q · filed 2014-11-14 |
| 2012-09-30 | $2.45M 10-Q · filed 2012-12-05 |
| 2012-06-30 | $2.14M 10-Q · filed 2012-12-05 |
| 2011-12-31 | $3.48M 10-Q · filed 2012-12-05 |